The development of nonmotor biomarkers to diagnose parkinson's disease subtypes early on…

The U.S. Department of the Army Medical Command awarded a $494,774 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to Aarhus Universitet, a Danish educational institution, to develop nonmotor biomarkers to diagnose Parkinson's disease subtypes early on. The award, which runs from December 15, 2024 to December 14, 2026, will support advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. Aarhus Universitet, a state-controlled university registered in the U.S. government's System for Award Management, has demonstrated significant capability in conducting complex research projects and providing specialized laboratory services, data analysis, and collaborative scientific investigations for U.S. federal agencies. The university frequently partners with prominent U.S. research institutions as a sub-grant recipient on projects spanning diverse fields, including medical research, marine biology, and interdisciplinary scientific collaborations.